NVCR
Novocure Ltd
NASDAQ: NVCR · HEALTHCARE · MEDICAL DEVICES
$11.93
-1.57% today
Updated 2026-04-29
Market cap
$1.38B
P/E ratio
—
P/S ratio
2.11x
EPS (TTM)
$-1.22
Dividend yield
—
52W range
$10 – $20
Volume
1.5M
Novocure Ltd (NVCR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+26.5%
Last 4 quarters
Revenue YoY growth
+8.1%
Most recent quarter
EPS YoY growth
+63.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.9%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.8%
2026-02-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.22 | +46.0% | $14.99 | $13.67 | -8.8% |
| 2025-10-30 | $-0.33 | +21.4% | $13.48 | $12.81 | -5.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.41 | $-0.22 | +46.0% | $174.35M | +8.1% |
| 2025-09-30 | $-0.42 | $-0.33 | +21.4% | $167.20M | +7.8% |
| 2025-06-30 | $-0.38 | $-0.36 | +5.3% | $158.81M | +5.6% |
| 2025-03-31 | $-0.46 | $-0.31 | +33.2% | $154.99M | +11.9% |
| 2024-12-31 | $-0.36 | $-0.61 | -69.4% | $161.27M | +20.5% |
| 2024-09-30 | $-0.33 | $-0.28 | +15.2% | $155.09M | +21.8% |
| 2024-06-30 | $-0.41 | $-0.31 | +24.4% | $150.36M | +19.3% |
| 2024-03-31 | $-0.42 | $-0.36 | +14.3% | $138.50M | — |
| 2023-12-31 | $-0.52 | $-0.45 | +13.5% | $133.78M | — |
| 2023-09-30 | $-0.52 | $-0.46 | +11.5% | $127.32M | — |
| 2023-06-30 | $-0.50 | $-0.54 | -8.0% | $126.05M | — |
Frequently asked questions
Has Novocure Ltd beaten earnings estimates?
Novocure Ltd has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +26.5% over the last 4 quarters.
How does NVCR stock react to earnings?
NVCR stock has moved an average of -6.9% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Novocure Ltd's revenue growth rate?
Novocure Ltd reported year-over-year revenue growth of +8.1% in its most recent quarter, with EPS growing +63.9% year-over-year.